Vote Scores
Filings read through

Maravai LifeSciences Holdings, Inc.: how funds voted at the meeting of 22 May 2025

Ticker
MRVI
Meeting
Season
year to 30 June 2025
Filers reporting
266
Ballot items
3

266 filers on Form N-PX reported votes at the Maravai LifeSciences Holdings, Inc. meeting of 22 May 2025. The records fall into 3 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Maravai LifeSciences Holdings, Inc. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    4 nominees. 59.7% of the reported votes are for. 61 filers withheld from or voted against at least one nominee.

    608 vote records from 89 filers. 28 of the 88 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 35 fund families
    • For 19
    • Abstain or withhold 15
    • Split or no vote 1
    • Against management 14
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    364 vote records from 266 filers. 171 of the 256 filers that marked the item voted against management. 10 filers gave no management mark.

    • Positions of 41 fund families
    • For 9
    • Against 31
    • Abstain or withhold 1
    • Against management 32
  3. Item 3: Audit-related items (auditor ratification)

    152 vote records from 89 filers. 0 of the 88 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 35 fund families
    • For 35

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Maravai LifeSciences Holdings, Inc., meeting of 22 May 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinAgainst, against managementNo report
American CenturyAgainst, against managementFor
BlackRock and iSharesAgainst, against managementFor
BNY MellonAgainst, against managementNo report
Brighthouse FundsAgainst, against managementFor
Charles SchwabAgainst, against managementFor
Columbia ThreadneedleForFor
DimensionalAgainst, against managementFor
DWSAgainst, against managementFor
EquitableAgainst, against managementFor
FidelityForFor
Franklin TempletonAbstain, against managementFor
Global XAgainst, against managementFor
Goldman SachsAgainst, against managementFor
Guggenheim and RydexAgainst, against managementFor
Harbor FundsForFor
InvescoAgainst, against managementFor
J.P. MorganForFor
Jackson National fundsAgainst, against managementFor
John Hancock and ManulifeAgainst, against managementFor
Lincoln FinancialForFor
MassMutualForNo report
MFSAgainst, against managementFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementFor
NationwideAgainst, against managementFor
Natixis and Loomis SaylesAgainst, against managementNo report
Neuberger BermanAgainst, against managementNo report
Northern Trust and FlexSharesForFor
Nuveen and TIAAAgainst, against managementFor
Pacific Life fundsAgainst, against managementFor
PGIM and PrudentialAgainst, against managementFor
PrincipalAgainst, against managementNo report
ProShares and ProFundsAgainst, against managementFor
Russell InvestmentsAgainst, against managementFor
SEIAgainst, against managementFor
State Street and SPDRForFor
T. Rowe PriceAgainst, against managementFor
TransamericaAgainst, against managementFor
VanguardForFor
Victory CapitalAgainst, against managementFor
VoyaAgainst, against managementFor

Questions

How many filers reported votes at the Maravai LifeSciences Holdings, Inc. meeting?
266 Form N-PX filers reported votes at the meeting of 22 May 2025. On say-on-pay, 171 of 256 filers that marked the item voted against management (66.8%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Maravai LifeSciences Holdings, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Maravai LifeSciences Holdings, Inc. with a meeting date within three days of 22 May 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .